Ligand validation:5CG2

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5CG2 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5CG2_NAD_A_500	90%	64%	0.084	0.966	0.63	0.76	-	1	0	0	100%	1
5CG2_NAD_B_500	53%	66%	0.14	0.901	0.57	0.75	-	2	2	0	100%	1
7UM8_NAD_A_301	96%	4%	0.069	0.976	3.83	1.79	17	12	0	0	100%	1
7UMW_NAD_A_301	95%	3%	0.067	0.972	4.57	1.75	14	8	0	0	100%	1
4D46_NAD_A_1258	92%	45%	0.086	0.976	1.02	1.11	2	6	0	0	100%	1
1QG6_NAD_B_502	90%	7%	0.074	0.958	2.39	2.52	14	15	0	0	100%	1
3PJF_NAD_A_501	84%	5%	0.094	0.954	3.57	1.75	28	8	0	0	100%	1
2O2Y_NAD_B_1450	100%	23%	0.024	0.995	1.79	1.4	5	3	1	0	100%	1
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.